reported that hypermethylation of RARB (aka RARß2) was significantly associated with a higher risk of prostate cancer in AA men but not in EA men, but this study was not included since it only evaluated cancer risk according to methylation within benign prostate tissue (126). The gene discussed is RARB; the disease is prostate cancer.